Exposure to Rifampicin and its Metabolite 25-Deacetylrifampicin Rapidly Decreases During Tuberculosis Therapy

Exposure to both RIF and 25-dRIF rapidly decreased during tuberculosis therapy. The contribution of 25-dRIF to overall drug exposure was low. Attainment of the target area under the concentration-time curve over 24 hours/minimum inhibitory concentration for RIF was poor, supporting an increased RIF dosage as an option to compensate for auto-induction.

Authors

Institutions

Publication Details

Journal
Clinical Pharmacokinetics
Published
2025-01-27
DOI
https://doi.org/10.1007/s40262-025-01479-3
Citations
2
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
2.79

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exposure to Rifampicin and its Metabolite 25-Deacetylrifampicin Rapidly Decreases During Tuberculosis Therapy

Charlotte Genestet, Tristan Ferry, François Parant, Clément Javaux et al.
2 citations
Clinical Pharmacokinetics
Tuberculosis Research and Epidemiology
2.79
article

Exposure to Rifampicin and its Metabolite 25-Deacetylrifampicin Rapidly Decreases During Tuberculosis Therapy

Charlotte Genestet, Tristan Ferry, François Parant, Clément Javaux, Paul Chabert, Sandrine Roux, Olivier Bahuaud, Oana Dumitrescu, Carole Chedid, Aurélien Millet, Rim Bayaa, Maxime Simon, Jonathan Hoffmann, Elisabeth Hodille, Florence Ader, Evelyne Braun, Gérard Lina, Agathe Becker, Sylvain Goutelle, Pierre Chauvelot, Anne Conrad, Florent Valour, T. Perpoint, Cécile Pouderoux
article en
2 citations

Abstract

Exposure to both RIF and 25-dRIF rapidly decreased during tuberculosis therapy. The contribution of 25-dRIF to overall drug exposure was low. Attainment of the target area under the concentration-time curve over 24 hours/minimum inhibitory concentration for RIF was poor, supporting an increased RIF dosage as an option to compensate for auto-induction.

Clinical PharmacokineticsVol. 64(3)
Université Claude Bernard Lyon 1 (FR), École Normale Supérieure de Lyon (FR), Centre National de la Recherche Scientifique (FR), Inserm (FR), Lyon College (US), Hôpital de la Croix-Rousse (FR), Hospices Civils de Lyon (FR), Laboratoire de Biométrie et Biologie Evolutive (FR), Centre International de Recherche en Infectiologie (FR)
Agence Nationale de la Recherche, Hospices Civils de Lyon
Good health and well-being
Openalex Percentile: Top 13%
Tuberculosis Research and Epidemiology
2.79
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.